Efficacy and Safety Study for an Oral Contraceptive Containing Folate

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether the study drug is safe and effective

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Drospirenone; Drospirenone and ethinyl estradiol combination; Ethinyl Estradiol; Folic Acid

Criteria

Inclusion Criteria:

• Healthy women between 18 and 40 requesting oral contraception

Exclusion Criteria:

• The use of steroidal oral contraceptives, or any drug that could alter Oral Contraception metabolism will be prohibited during the study